Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6547060

CC(c1ccc[nH]1)S(=O)(=O)O.Cl.O=C(O)Cc1ccc[nH]1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GABRA1 known ✓ P14867 1/20 0.30
GABRA5 known ✓ P31644 1/20 0.30
GABRB2 known ✓ P47870 1/20 0.30
GABRA4 known ✓ P48169 1/20 0.30
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
PMP22 Q01453 1/20 0.33
TSHR P16473 2/20 0.32
CYP3A4 P08684 1/20 0.30
NFKB1 P19838 1/20 0.30
GABRR1 P24046 1/20 0.30
GABRR2 P28476 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6547242 0.82 DAO (0.33) ALDH1A1KDM4EMAPTPMP22
Hydrochloric Acid SCHEMBL6546575 0.79 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTPMP22TSHR
SCHEMBL253592 0.77
Bromide SCHEMBL27470986 0.75 TSHR (0.46) ALDH1A1KDM4EMAPTPMP22TSHR
Pyridine SCHEMBL28090960 0.68 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTPMP22TSHR
SCHEMBL13546077 0.68 CYP1A2 (0.40) TSHR
SCHEMBL6019018 0.66 FFAR1 (0.44) KDM4EMAPTTSHR
SCHEMBL6338128 0.65
SCHEMBL8847499 0.65 KDM4E (0.36) ALDH1A1KDM4EMAPTPMP22TSHR
SCHEMBL8908954 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020052026-A1 METHODS OF REFOLDING PROTEINS GENETICS INSTITUTE, LLC 2002-05-02 US claimed
EP-1021528-A1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS GENETICS INSTITUTE, INC. (US) 2000-07-26 EP claimed
WO-1999018196-A1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS GENETICS INSTITUTE, INC. (US) 1999-04-15 WO claimed
EP-1021528-B1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS INST GENETICS LLC (US) 2004-01-28 EP disclosed
US-6632635-B1 Useful in improved processes for preparation of biologically active dimeric recombinant bone morphogenetic proteins using acid substituted aminocyclohexanes GENETICS INSTITUTE 2003-10-14 US disclosed
US-6596511-B1 Expression of transforming growth factor protein; culture prokaryotic cells containing sequences coding transforming growth factor, express nucleotide sequences, fold protein in fluid containing trigonelline hydrochloride GENETICS INSTITUTE LLC 2003-07-22 US disclosed
US-6593106-B1 Culturing prokaryotic cells which have been transformed with a DNA encoding a transforming growth factor protein; substituted pyrroles; useful in preparation of bone morphogenetic proteins GENETICS INSTITUTE LLC 2003-07-15 US disclosed
US-6593107-B1 Culturing prokaryotic cells which have been transformed with a DNA encoding a transforming growth factor; pyridine 3-sulfonic acid; useful in preparation of bone morphogenetic proteins GENETICS INSTITUTE LLC 2003-07-15 US disclosed
US-20020052026-A1 METHODS OF REFOLDING PROTEINS GENETICS INSTITUTE, LLC 2002-05-02 US disclosed
EP-1021528-A1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS GENETICS INSTITUTE, INC. (US) 2000-07-26 EP disclosed
WO-1999018196-A1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS GENETICS INSTITUTE, INC. (US) 1999-04-15 WO disclosed